News & Insights
Blumberg Capital portfolio news, startup growth resources and industry insights
Home > News & Insights >
SmithRx Raises $9 Million for Bespoke Drug Benefits Platform
Jan 11, 2018
By Heather Mack
SmithRx, which has developed a platform for drug price negotiation and sales, has raised $9 million in Series A funding.
Founders Fund led the investment, with participation from Blumberg Capital, Box Group, NextGen Venture Partners and others. The funding is to be used for expansion efforts.
Related Articles
